¹ Strategic Partnering to Evaluate Cancer Signatures

RFA-CA-04-015
Letter of Intent Receipt Date: June 22, 2004
Application Receipt Date: July 22, 2004

NCI invites investigators to form strategic partnerships that will bring together the multidisciplinary expertise and resources needed to determine how information derived from comprehensive molecular analyses can be used to improve patient care and, ultimately, patient outcomes. This RFA focuses on the translation of promising molecular profiles to clinical application, with primary goals of confirming, refining, and evaluating the molecular signatures and developing robust clinical assays.

For more information see http://cri.nci.nih.gov.

Inquiries: James W. Jacobson, jacobsoj@mail.nih.gov;
Tracy G. Lugo, lugot@mail.nih.gov